STRC Hypothesis Ranking
Live tier table across all 18 numbered hypotheses (h01–h16, h26, h27). Every row links to its hypothesis hub with phase history and artifacts. Scores update as proofs land.
Rubric
Axes 1-5: Mech (biology plausible), Deliv (cochlear delivery 3-5 yr), Misha-fit (compound het, age, OHC window).
Tier heuristic: min(Mech, Deliv, Misha-fit). S = top 5 active. A = backburner. B = watch. C = paused, needs external catalyst. D = killed.
Active register
All 18 numbered hypotheses. Ref rows (supporting notes, clinical plans) appear separately below.
TABLE WITHOUT ID
hypothesis_num AS "#",
link(hypothesis_title) AS "Hypothesis",
mech AS "Mech",
deliv AS "Deliv",
misha_fit AS "Misha",
tier AS "Tier",
next_step AS "Next step",
file.link AS "Hub"
FROM "hypotheses"
WHERE type = "hypothesis-hub"
SORT hypothesis_num ASC| # | Hypothesis | Mech | Deliv | Misha | Tier | Next step | Hub |
|---|---|---|---|---|---|---|---|
| 1 | STRC Pharmacochaperone Virtual Screen E1659A | 3 | 4 | 4 | A | Phase 5e mutant re-dock running (v3b YELLOW pocket-stability gate); then Phase 3c v4 fragment-grow on 3-amino-benzofuran-2-COOH scaffold | index |
| 2 | STRC Piezoelectric TM Bioelectronic Amplifier | 2 | 1 | 5 | B | Find OHC ligand + FEM strain-share | index |
| 3 | STRC Mini-STRC Single-Vector Hypothesis | 5 | 5 | 4 | S | Order gBlock, clone pAAV, coIP | index |
| 4 | STRC mRNA-LNP Strategy B Full-Length | 3 | 2 | 2 | B | Academic/interim if AAV fails | index |
| 5 | STRC Calcium Oscillation Acoustic Therapy | 3 | 4 | 2 | A | SPR/BLI E1659A affinity penalty | index |
| 6 | STRC mRNA Therapy Hypothesis | 2 | 2 | 2 | B | Retrieve OHC RBM24 titration lit | index |
| 7 | Prime Editing for STRC | 3 | 2 | 1 | C | Wet-lab ribosome-profiling STRCP1 | index |
| 8 | STRC ASO Exon Skipping | 2 | 3 | 2 | C | Phase 3a morpholino + 3b gapmer | index |
| 9 | STRC Synthetic Peptide Hydrogel HTC | 4 | 3 | 3 | A | Phase 2c WH2 bundling + 4b AF3 | index |
| 10 | STRC In Situ SpyCatcher Assembly | 2 | 2 | 2 | C | Wet-lab only if #3 fails | index |
| 11 | STRC Engineered TECTA Chimera | 2 | 2 | 2 | C | Alt scaffold deferred | index |
| 12 | Sonogenetic STRC Computational Proof | 2 | 2 | 2 | C | Speculative; no near-term path | index |
| 13 | STRC Programmable Recombinases | 2 | 1 | 3 | C | Technology-watch only | index |
| 14 | STRC Protein Replacement Therapy | 2 | 1 | 3 | C | No delivery route | index |
| 15 | STRC OTOA Paralog Cross-Rescue | 2 | 2 | 2 | D | Chimera dead; upregulation weak | index |
| 16 | STRC ZP Domain Prion-Like Seeding | 3 | 2 | 1 | D | Wrong patient (paternal 98kb Δ) | index |
| 26 | STRC Engineered Homodimer Avidity | 2 | 5 | 4 | B | Phase 1d AF3 A1078C/S1080C/S1579C | index |
| 27 | STRC STRCP1 Activation Rescue | 2 | 2 | 4 | C | Email Holt lab ribosome-profiling | index |
Supporting notes (ref — no hub, not in active register)
These hypotheses/models feed into the active register above but don’t get their own hypothesis-hub folder. They’re either engineering sub-layers, survey notes, or clinical strategy docs.
| Hypothesis / model | Role |
|---|---|
| STRC RBM24 Regulatory Hypothesis | Rolled into Strategy A |
| STRC Stereocilia Bundle Mechanics Model | Supporting biophysics model |
| STRC AAV Vector Design | Mini-STRC implementation detail |
| STRC B8 Enhancer Selection | AAV pipeline |
| STRC Dual-Vector vs Single-Vector Transduction | Engineering layer |
| STRC Anti-AAV Immune Response Model | Re-dosing constraint |
| STRC Electrostatic Analysis E1659A | Pharmacochaperone input |
| Adult Treatment Window STRC | Constraint on all mechanisms |
| Alternative STRC Delivery Hypotheses | Delivery-layer survey |
| Misha Compound-Het Therapy Stack Model | Clinical plan: parallel h01+h03 stack |
S-tier (live)
TABLE WITHOUT ID
link(hypothesis_title) AS "Hypothesis",
next_step AS "Next step",
file.link AS "Hub"
FROM "hypotheses"
WHERE type = "hypothesis-hub" AND tier = "S"
SORT hypothesis_num ASC| Hypothesis | Next step | Hub |
|---|---|---|
| STRC Mini-STRC Single-Vector Hypothesis | Order gBlock, clone pAAV, coIP | index |
Clinical plan for Misha per Misha Compound-Het Therapy Stack Model: pursue #1 (PC for maternal E1659A) + #3 (AAV for paternal null) in parallel. h01 is the only monotherapy route to NORMAL (≤ 25 dB ABR); stack provides redundancy and lower drug/AAV burden. Phase 5 MD on #1 is the critical-path compute that produces the f_PC parameter.
Kill list (D-tier, live)
TABLE WITHOUT ID
link(hypothesis_title) AS "Hypothesis",
next_step AS "Reason killed",
file.link AS "Hub"
FROM "hypotheses"
WHERE type = "hypothesis-hub" AND tier = "D"
SORT hypothesis_num ASC| Hypothesis | Reason killed | Hub |
|---|---|---|
| STRC OTOA Paralog Cross-Rescue | Chimera dead; upregulation weak | index |
| STRC ZP Domain Prion-Like Seeding | Wrong patient (paternal 98kb Δ) | index |
Decision gates
- → D: mechanism falsified OR Misha-fit=1 OR delivery impossible 10 yr.
- → C: no near-term computational step; log external catalyst.
- → B: evidence neutral, shallow engagement.
- → A: real progress possible, not highest-leverage today.
- → S: top 5 max, advances Misha directly, actionable next step.
Literature-audit status
Per-hypothesis audit of parameter provenance against primary literature. Status (fixed / partial / deferred) is carried on each hub.
TABLE WITHOUT ID
hypothesis_num AS "#",
link(hypothesis_title) AS "Hypothesis",
tier AS "Tier",
lit_audit AS "Audit",
lit_audit_date AS "Date",
file.link AS "Hub"
FROM "hypotheses"
WHERE type = "hypothesis-hub"
SORT hypothesis_num ASC| # | Hypothesis | Tier | Audit | Date | Hub |
|---|---|---|---|---|---|
| 1 | STRC Pharmacochaperone Virtual Screen E1659A | A | fixed | 2026-04-23 | index |
| 2 | STRC Piezoelectric TM Bioelectronic Amplifier | B | fixed | 2026-04-23 | index |
| 3 | STRC Mini-STRC Single-Vector Hypothesis | S | deferred | 2026-04-23 | index |
| 4 | STRC mRNA-LNP Strategy B Full-Length | B | fixed | 2026-04-23 | index |
| 5 | STRC Calcium Oscillation Acoustic Therapy | A | fixed | 2026-04-23 | index |
| 6 | STRC mRNA Therapy Hypothesis | B | partial | 2026-04-23 | index |
| 7 | Prime Editing for STRC | C | fixed | 2026-04-23 | index |
| 8 | STRC ASO Exon Skipping | C | fixed | 2026-04-23 | index |
| 9 | STRC Synthetic Peptide Hydrogel HTC | A | partial | 2026-04-23 | index |
| 10 | STRC In Situ SpyCatcher Assembly | C | fixed | 2026-04-23 | index |
| 11 | STRC Engineered TECTA Chimera | C | fixed | 2026-04-23 | index |
| 12 | Sonogenetic STRC Computational Proof | C | deferred | 2026-04-23 | index |
| 13 | STRC Programmable Recombinases | C | deferred | 2026-04-23 | index |
| 14 | STRC Protein Replacement Therapy | C | deferred | 2026-04-23 | index |
| 15 | STRC OTOA Paralog Cross-Rescue | D | deferred | 2026-04-23 | index |
| 16 | STRC ZP Domain Prion-Like Seeding | D | deferred | 2026-04-23 | index |
| 26 | STRC Engineered Homodimer Avidity | B | fixed | 2026-04-23 | index |
| 27 | STRC STRCP1 Activation Rescue | C | fixed | 2026-04-23 | index |
- 2026-04-23-digest — latest literature-watch auto-digest (1 new paper, 45 filtered)
Legacy synthesis pages (pre-hub structure)
Older flat synthesis notes from 2026-04-21/22, superseded by the h{N}/hub.md structure but kept for historical context:
- delivery — sonoporation + LNP through round window (now in h04-mrna-lnp)
- dual-vector — dual vs single vector math (now referenced by h03-mini-strc)
- electrostatics — E1659A electrostatic analysis (reference tier)
- immune — anti-AAV antibodies + re-dosing (supporting)
- mini-strc — mini-STRC synthesis (now h03-mini-strc)
- prime-editing — prime editing feasibility (now h07-prime-editing)
- sonogenetics — sound-activated gene expression (now h12-sonogenetic)
Connections
[part-of]STRC Research Portal[see-also]STRC Hypothesis Ranking Log[see-also]STRC Mini-STRC Single-Vector Hypothesis[see-also]STRC Pharmacochaperone Virtual Screen E1659A[see-also]STRC Piezoelectric TM Bioelectronic Amplifier[see-also]STRC Calcium Oscillation Acoustic Therapy[see-also]STRC Synthetic Peptide Hydrogel HTC[about]Misha